⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Growth Hormone Receptor Antagonists
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-07 — Mice With Growth Hormone Halted in Middle Age Live Longer: cross-connection with growth-hormone-receptor-inhibition: Midlife genetic GHR halt extending mouse lifespan strengthens the translational rationale for pharmacological GHR antagonists (e.g. pegvisomant-class) as late-life geroprotectors rather than requiring lifelong exposure. (novelty: 3)
- 2026-09-06 — Growth Hormone Receptor Antagonism Extends Lifespan: Preclinical report that pharmacological GH receptor antagonism extends lifespan in animals, extending the long-established GHRKO/dwarf-mouse longevity phenotype from genetic knockout to drug-level intervention. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Growth Hormone Receptor Antagonism Extends Lifespan
06-sep-2026
novelty 3
per-area 3
strengthens